Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 22, 2017

Primary Completion Date

November 3, 2018

Study Completion Date

November 3, 2018

Conditions

Severe Hemophilia A

Interventions

DRUG

Wilate

von Willebrand factor / Factor VIII (plasma derived)

Trial Locations (3)

Kirov SSC Hematology and Transfusiology, Kirov

"National Children's Specialized Clinic OKHMATDYT", Kyiv

"Western Ukrainian Specialized Children's Medical Center", Lviv